This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Eknath Kundlik Khemnar: Innovator in Pharmaceutical Processes
Introduction
Eknath Kundlik Khemnar is a notable inventor based in Ahmednagar, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of specific compounds. His work is characterized by innovative processes that enhance the efficiency and effectiveness of drug development.
Latest Patents
Eknath holds a patent for a process related to the preparation of ospemifene. This invention involves a method that recycles undesired compounds to generate an isomeric mixture of Z,E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol. This process not only improves the yield of the desired compound but also contributes to more sustainable pharmaceutical practices. He has 1 patent to his name.
Career Highlights
Eknath is currently associated with Glenmark Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His role at Glenmark allows him to apply his innovative ideas in a practical setting, contributing to the development of new medications and therapies.
Collaborations
Eknath has worked alongside talented colleagues such as Veerabhadra Swamy and Kumar Hari Bhushan. Their collaborative efforts have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Eknath Kundlik Khemnar is a distinguished inventor whose work in pharmaceutical processes exemplifies innovation and dedication. His contributions, particularly in the preparation of ospemifene, highlight the importance of sustainable practices in drug development. His career at Glenmark Pharmaceuticals Limited and collaborations with esteemed colleagues further underscore his impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
